Johnson & Johnson’ s €4bn four part bond touches investor’s ‘sweet spot’
US biopharmaceutical firm Johnson & Johnson on Wednesday issued a four tranche bond, including 19 year notes, amid much competition in a market that absorbed 17 deals this week.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: